Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$0.28 - $1.16 $140 - $580
500 Added 166.67%
800 $0
Q1 2024

Jul 22, 2024

BUY
$1.06 - $1.67 $318 - $501
300 New
300 $0
Q2 2022

Aug 15, 2022

BUY
$2.2 - $4.2 $1,320 - $2,520
600 Added 120.0%
1,100 $3,000
Q4 2021

Feb 16, 2022

SELL
$8.31 - $14.92 $56,092 - $100,710
-6,750 Reduced 93.1%
500 $4,000
Q3 2021

Nov 15, 2021

BUY
$9.15 - $13.28 $66,337 - $96,280
7,250 New
7,250 $84,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.6B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.